Insider filings made public Wednesday show a mix of concentrated purchases by executives and large-scale disposals by certain major holders across several sectors. The most significant purchases included transactions by Occidental Petroleum's chief executive and by insiders at smaller-cap and oil-and-gas related names. At the same time, prominent sales were reported for companies in digital health, retail and cloud computing-related businesses.
Summary of top purchases
-
Cross Timbers Royalty Trust - Eric L. Oliver and affiliated entities SoftVest, LP and SoftVest GP I, LLC acquired a total of 55,564 units of beneficial interest for combined consideration of $481,666. The transactions occurred on June 22 and June 23, 2026, at prices ranging from $8.65 to $8.68 per unit. The Trust's units were trading near $8.67 at the time of the filings, having declined roughly 3% over the prior week and about 6% over the last year. The purchases were executed indirectly by SoftVest, LP, with SoftVest GP I, LLC serving as the general partner; Eric L. Oliver is listed as the managing member of SoftVest GP I, LLC. Mr. Oliver disclaims beneficial ownership except to the extent of his pecuniary interest.
-
Occidental Petroleum Corp - Richard A. Jackson, President and Chief Executive Officer, purchased 4,770 shares at $52.38 per share, for total consideration of $249,852. The transaction was reported on June 23, 2026. At the time of disclosure, Occidental stock was trading at $51.10 and had risen nearly 29% over the prior six months. Following this purchase, Mr. Jackson directly holds 444,098 shares of Occidental common stock and indirectly holds 10,052 shares through the OPC Savings Plan, based on a plan statement dated June 23, 2026. The company has a 53-year record of dividend payments and a current yield of 2.04%.
-
Faeth Therapeutics, Inc. - Brian C. Stephenson, Chief Financial Officer, acquired common stock valued at $405,920 across purchases on June 22 and June 23, 2026. The reported price range for the transactions was $20.23 to $25.91 per share. The stock was trading at $24.54, representing a 47% gain over the previous week and a 190% increase over the past year. These shares were acquired indirectly through the Brian Stephenson Revocable Trust, where Mr. Stephenson serves as sole trustee and holds sole voting and investment power over its securities. He disclaims beneficial ownership of the shares except to the extent of his pecuniary interest.
-
TXO Partners, L.P. - Bob R Simpson, director and ten percent owner, bought a total of 100,000 common units on June 22 and June 23, 2026. The aggregate value of the purchases was approximately $1.26 million. On June 22 specifically, Mr. Simpson purchased 36,718 units at a weighted average price of $12.5545 per unit, with individual trades executed between $12.52 and $12.60. The company offers a dividend yield of 11.67%, noted in the disclosure.
-
CarMax Inc - Keith Barr, President and Chief Executive Officer, purchased 9,400 shares of CarMax common stock on June 22, 2026, at $53.005 per share, totaling $498,247. After the transaction, Mr. Barr directly holds 33,375 shares. At the time of the filing, the stock traded at $50.77, slightly below the purchase price, though shares had risen 9.5% over the prior week. The filing also notes active share repurchases by management.
Summary of major sales
-
Hinge Health, Inc. - Insight Holdings Group, LLC and affiliated entities, listed as a ten percent owner, reported the sale of 727,793 shares of Hinge Health Class A Common Stock for total proceeds of approximately $51.6 million. These transactions took place between June 22 and June 24, 2026, with weighted average prices ranging from $70.2145 to $71.6669 per share and individual trade prices between $70.000 and $72.075 per share. At the time of the filing, the stock was trading at $70.56, roughly 1% below its 52-week high of $72.39, after a 58% gain over the past year.
-
Citi Trends Inc - Fund 1 Investments, LLC, identified as a 10% owner, sold 750,000 shares on June 24, 2026, receiving $42,375,000 at $56.50 per share. The filing notes that after the sale, Fund 1 Investments, LLC indirectly holds 1,823,486 shares of Citi Trends common stock. The securities are held by private investment vehicles advised by Pleasant Lake Partners LLC, with Fund 1 Investments, LLC as managing member of Pleasant Lake Partners LLC and Jonathan Lennon as managing member of Fund 1 Investments, LLC. Citi Trends stock was trading at $63.44, having gained 109% over the prior year and trading near its 52-week high of $66.38.
-
Enliven Therapeutics, Inc. - Investment entities OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital GP VII LLC sold a combined 860,123 shares on June 22, 2026, generating approximately $39,014,045. The shares were sold at prices between $45.00 and $45.38 per share. The stock was trading near its 52-week high of $49.94 and had risen 210% year-to-date. The disclosure lists a market capitalization of $2.96 billion.
-
CoreWeave, Inc. - Brannin McBee, Chief Development Officer, sold 195,000 shares of Class A Common Stock on June 22, 2026, raising roughly $21,921,284. The sales were executed through two irrevocable trusts - the Brannin J. McBee 2022 Irrevocable Trust and the Canis Major 2024 Irrevocable Trust LLC - and were part of a Rule 10b5-1 trading plan adopted on March 5, 2026. Sale prices ranged from $107.051 to $119.0 per share. Of the total, 143,000 shares were held directly by Mr. McBee, 24,000 shares were sold indirectly by his spouse, and 28,000 shares were sold through the trusts in separate transactions. The stock was trading at $100.88, down 12.4% over the prior week.
Contextual notes on holdings and prices
The filings specify ownership structures and how transactions were executed. In a number of cases purchases were made indirectly through trusts or affiliated partnerships, with the filers disclaiming beneficial ownership aside from pecuniary interest where indicated. Prices reported in the filings span a broad range - from single-digit unit prices for trust interests to triple-digit per-share prices for certain technology-adjacent companies - and the accompanying disclosures include short-term and 12-month performance figures for the securities involved.
Why these filings matter
Insider transactions reveal the actions taken by those with access to detailed company information and by significant holders. Purchases by executives or directors often are viewed as expressions of conviction in the company at that specific point in time. Large sales, particularly by ten percent owners or institutional investment entities, can reflect portfolio rebalancing, monetization of gains, or other investor-specific motivations. However, the filings do not provide the motivations behind the trades; they only document timing, amounts, pricing and the ownership structure through which the trades were executed.
Key takeaways
- Insiders and major holders disclosed sizeable transactions across sectors including energy, retail, health care and infrastructure-related technology.
- Notable purchases included a direct buy by Occidental Petroleum's CEO and purchases via trusts and affiliated entities for smaller-cap and royalty interests.
- Large block sales were concentrated in growth and retail names such as Hinge Health and Citi Trends, with each holder realizing proceeds measured in the tens of millions of dollars.
Risks and uncertainties highlighted by the filings
- Insider sales do not disclose the sellers' motivations - sales by large holders could reflect personal or fund-level liquidity needs rather than valuation or outlook changes; this applies across sectors where block sales were reported.
- Purchases executed indirectly through trusts or affiliated entities limit clarity on beneficial ownership and the degree of voting or investment control, which can complicate assessments of insider conviction.
- Short-term price volatility noted in the filings - including week-over-week moves of double-digit percentages for some names - introduces timing risk for investors interpreting a single filing as a definitive signal.
Concluding observation
The filings released Wednesday document a mixture of targeted insider accumulation and substantial disposals by large stakeholders. The disclosures provide precise transaction details - quantities, prices, dates and ownership mechanics - that investors and analysts can incorporate into broader fundamental and risk assessments. They do not, however, illuminate the personal motives behind each trade, which remains a limitation when using insider activity as a standalone indicator.